These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reversibility of atherosclerosis--evolving perspectives from two arterial imaging clinical trials: the cholesterol lowering atherosclerosis regression study and the monitored atherosclerosis regression study. Hodis HN J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S25-31. PubMed ID: 8907211 [TBL] [Abstract][Full Text] [Related]
3. Lipid risk factors and the regression of atherosclerosis. Gotto AM Am J Cardiol; 1995 Jul; 76(2):3A-7A. PubMed ID: 7604793 [TBL] [Abstract][Full Text] [Related]
4. [The relationship between clinical events and the angiographic lesions in coronary atherosclerosis. Hypolipemic treatment and plaque stabilization]. Castro Beiras A; Vázquez Rodríguez JM; Muñiz J; Calviño R; Vázquez González N; Juane R Rev Esp Cardiol; 1995; 48 Suppl 5():23-30. PubMed ID: 7494936 [TBL] [Abstract][Full Text] [Related]
5. [Hypolipemic therapy in peripheral arterial diseases: reasons of its clinical use]. Balbarini A; Coli S Cardiologia; 1999 Feb; 44(2):137-45. PubMed ID: 10208050 [No Abstract] [Full Text] [Related]
6. Discrimination of human arterial pathology by computer processing of angiograms for serial assessment of atherosclerosis change. Brooks SH; Crawford DW; Selzer RH; Blankenhorn DH; Barndt R Comput Biomed Res; 1978 Oct; 11(5):469-80. PubMed ID: 367702 [No Abstract] [Full Text] [Related]
7. Predilection of atherosclerosis for the inner curvature in the femoral artery. A digitized angiography study. Smedby O; Johansson J; Mölgaard J; Olsson AG; Walldius G; Erikson U Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):912-7. PubMed ID: 7600123 [TBL] [Abstract][Full Text] [Related]
8. Femoral and coronary angiographic trials. Cashin-Hemphill L Am J Cardiol; 1993 Feb; 71(6):20B-25B. PubMed ID: 8434557 [TBL] [Abstract][Full Text] [Related]
9. Probucol Quantitative Regression Swedish Trial: new angiographic technique to measure atheroma volume of the femoral artery. Erikson U; Nilsson S; Stenport G Am J Cardiol; 1988 Jul; 62(3):44B-47B. PubMed ID: 3293416 [TBL] [Abstract][Full Text] [Related]
10. Studies of regression/progression of atherosclerosis in man. Blankenhorn DH Adv Exp Med Biol; 1977; 82():453-8. PubMed ID: 920402 [TBL] [Abstract][Full Text] [Related]
11. Distribution of coronary atherosclerosis and its correlation to metabolic risk factors and femoral atherosclerosis. Bergstrand L; Bylund H; Erikson U; Helmius G; Lidell C; Sundlöf G; Vessby B Acta Radiol; 1994 Sep; 35(5):481-6. PubMed ID: 8086259 [TBL] [Abstract][Full Text] [Related]
12. Computer densitometry for angiographic assessment of arterial cholesterol content and gross pathology in human atherosclerosis. Crawford DW; Brooks SH; Selzer RH; Barndt R; Beckenbach ES; Blankenhorn DH J Lab Clin Med; 1977 Feb; 89(2):378-92. PubMed ID: 833474 [TBL] [Abstract][Full Text] [Related]
13. Regression of computer estimated femoral atherosclerosis after pronounced serum lipid lowering in patients with asymptomatic hyperlipidaemia. Olsson AG; Carlson LA; Erikson U; Hemius G; Hemmingsson A; Ruhn G Lancet; 1982 Jun; 1(8284):1311. PubMed ID: 6123054 [No Abstract] [Full Text] [Related]
14. Should separate endpoint trials be required for all lipid-lowering drugs acting by the same mechanism? Shepherd J; Olsson AG; Sacks FM; Black DM; Orloff DG; Bilheimer DW Am J Cardiol; 1998 Apr; 81(8A):88F-94F. PubMed ID: 9604922 [No Abstract] [Full Text] [Related]
15. Plaque stabilization: the role of lipid lowering. Lee RT Int J Cardiol; 2000 Jun; 74 Suppl 1():S11-5. PubMed ID: 10856768 [TBL] [Abstract][Full Text] [Related]